Jakafi 50881-0015
Generic: Ruxolitinib
Product NDC
50881-0015- Manufacturer
- Incyte Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 16, 2011
- Listing Expires
- December 31, 2027
- Application
- NDA202192
Need to source Jakafi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ruxolitinib | 15 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]
Packaging Options(1)
60 TABLET in 1 BOTTLE, PLASTIC (50881-015-60)